Evicenter
MarkdownMedical informationP&T meetings
Ersodetug (RZ358)

Tumor hyperinsulinism

Manufacturer
Rezolute
Launch
Not announced
Last updated
140 sources

Product information and disease descriptionPlace of product in therapyDisease descriptionBurden of Tumor hyperinsulinism

Economic burden and healthcare resource utilization

7 evidence topics · 7 sources

Cost-of-illness or claims-based cost studies of insulinoma or NICTH

No evidence found.